Elite Pharmaceuticals Inc (ELTP)

[lasers]

You are misunderstanding the entire point of the ALO-02 ADCOM conversations conclusions.

Quite simply the ADCOM members are looking for higher standards guidlines from the FDA in which case both Teva's Vantrela and Pfizer's Troxyca ER would have both been rejected.

Based on current FDA guidelines both Teva's Vantrela and Pfizer's Troxyca ER were voted acceptable but would require label warnings.